Influenza vaccination of pregnant women and protection of their infants.

Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ (2015) 2.03

Incidence of influenza virus infection among pregnant women: a systematic review. BMC Pregnancy Childbirth (2017) 1.39

Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17

Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 1.09

Detectable Risks in Studies of the Fetal Benefits of Maternal Influenza Vaccination. Am J Epidemiol (2016) 0.97

Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis (2016) 0.93

Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One (2015) 0.86

Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants. J Infect Dis (2015) 0.85

Maternal vaccination for the prevention of influenza: current status and hopes for the future. Expert Rev Vaccines (2016) 0.84

Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG (2016) 0.84

Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review. Influenza Other Respir Viruses (2016) 0.84

Advancements in the development of subunit influenza vaccines. Microbes Infect (2014) 0.82

The Effect of Influenza Vaccination on Birth Outcomes in a Cohort of Pregnant Women in Lao PDR, 2014-2015. Clin Infect Dis (2016) 0.82

Influenza immunization among Canadian health care personnel: a cross-sectional study. CMAJ Open (2016) 0.82

Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015). Hum Vaccin Immunother (2015) 0.81

Invited Commentary: Influenza, Influenza Immunization, and Pregnancy-It's About Time. Am J Epidemiol (2016) 0.81

Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 0.80

The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design. Med Res Rev (2016) 0.80

Influenza immunization during pregnancy: Benefits for mother and infant. Hum Vaccin Immunother (2016) 0.80

The Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza. Influenza Other Respir Viruses (2015) 0.80

Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy. Front Immunol (2015) 0.79

Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement. PLoS One (2017) 0.79

Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy. J Prev Med Hyg (2016) 0.79

Circulating Influenza Virus and Adverse Pregnancy Outcomes: A Time-Series Study. Am J Epidemiol (2016) 0.78

Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns. Front Immunol (2016) 0.78

Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study. Clin Infect Dis (2016) 0.78

Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy. PLoS One (2016) 0.77

Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012-2015. Open Forum Infect Dis (2017) 0.77

Vaccines in pregnancy: The dual benefit for pregnant women and infants. Hum Vaccin Immunother (2016) 0.76

Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua. Pediatr Infect Dis J (2016) 0.76

Review on the effects of influenza vaccination during pregnancy on preterm births. Hum Vaccin Immunother (2015) 0.76

The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants. Clin Infect Dis (2016) 0.76

Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine (2016) 0.75

A retrospective review of birth outcomes at the Mother and Child Health Hospital in Lao People's Democratic Republic, 2004-2013. BMC Pregnancy Childbirth (2016) 0.75

Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis. PLoS One (2017) 0.75

Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination. PLoS One (2016) 0.75

Hutcheon et al. Respond to "Maternal Influenza Immunization and Birth Outcomes". Am J Epidemiol (2016) 0.75

THE AUTHORS REPLY. Am J Epidemiol (2017) 0.75

Contribution of serology assays in the evaluation of influenza virus infection rates and vaccine efficacy in pregnant women: Report from randomized controlled trials. Clin Infect Dis (2017) 0.75

Perception and Attitudes of Korean Obstetricians about Maternal Influenza Vaccination. J Korean Med Sci (2016) 0.75

Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial. Expert Rev Vaccines (2016) 0.75

ACP Journal Club: IIV3 reduced flu in HIV- pregnant women and infants, and in HIV+ pregnant women but not their infants. Ann Intern Med (2015) 0.75

Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies. Vaccine (2016) 0.75

The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age. Paediatr Child Health (2014) 0.75

The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age. Paediatr Child Health (2014) 0.75

Seasonal influenza vaccination in pregnant women: knowledge, attitudes, and behaviors in Italy. BMC Infect Dis (2017) 0.75

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I. Infect Dis Ther (2017) 0.75

Community-acquired pneumonia in children - a changing spectrum of disease. Pediatr Radiol (2017) 0.75

Immunization During Pregnancy: Impact on the Infant. Paediatr Drugs (2017) 0.75

Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review. BMJ Open (2017) 0.75

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86

Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09

Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med (2010) 6.56

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52

Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60

Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis (2005) 5.58

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet (2010) 5.43

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med (2004) 4.75

Viral etiology of severe pneumonia among Kenyan infants and children. JAMA (2010) 4.41

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet (2010) 4.26

Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis (2002) 4.08

Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04

Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet (2013) 3.98

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis (2003) 3.93

Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med (2010) 3.81

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis (2004) 3.75

Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis (2005) 3.72

Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med (2004) 3.49

A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med (2004) 3.49

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med (2011) 3.29

Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23

The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92

The burden of influenza-associated critical illness hospitalizations. Crit Care Med (2014) 2.84

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis (2005) 2.81

Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics (2013) 2.79

Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J (2009) 2.73

5' flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites. Mol Microbiol (2007) 2.72

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet (2013) 2.64

Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog (2008) 2.59

Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health Organ (2005) 2.50

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50

Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis (2007) 2.49

Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio (2011) 2.48

Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J (2013) 2.47

Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med (2003) 2.46

Pneumococcal vaccination in developing countries. Lancet (2006) 2.45

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS (2005) 2.24

Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS One (2011) 2.21

Soil Respiration in European Grasslands in Relation to Climate and Assimilate Supply. Ecosystems (2008) 2.17

Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother (2005) 2.14

Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis (2008) 2.11

Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose. J Infect Dis (2013) 2.10

Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol (2003) 2.09

Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis (2002) 2.07

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine (2007) 2.07

Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J (2007) 2.06

Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis (2005) 2.05

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest (2012) 2.05

Global distribution of novel rhinovirus genotype. Emerg Infect Dis (2008) 2.03

Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis (2005) 2.03

Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2006) 1.98

Clinical practice guideline: Polysomnography for sleep-disordered breathing prior to tonsillectomy in children. Otolaryngol Head Neck Surg (2011) 1.96

Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected children. J Infect Dis (2007) 1.95

Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet (2009) 1.95

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis (2009) 1.92

Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis (2003) 1.91

Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med (2014) 1.84

Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis (2009) 1.82

Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. Lancet Infect Dis (2010) 1.82

Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med (2011) 1.82

Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet (2008) 1.82

Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis (2012) 1.76

Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis (2005) 1.74

Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis (2009) 1.69

Otitis media and its consequences: beyond the earache. Lancet Infect Dis (2010) 1.68

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis (2002) 1.66

Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis (2011) 1.63

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol (2008) 1.63

Clinical redesign using all patient refined diagnosis related groups. Pediatrics (2004) 1.62

Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis (2012) 1.61

Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS (2012) 1.59

Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr (2006) 1.56

Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis (2013) 1.55

Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy. PLoS One (2012) 1.55

Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother (2004) 1.53

Pneumococcal vaccines and flu preparedness. Science (2007) 1.50

Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis (2003) 1.50

Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg Infect Dis (2008) 1.48

The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions. PLoS One (2012) 1.47

Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetil. Clin Infect Dis (2012) 1.47

Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J (2011) 1.45

Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in a South African child in a tuberculosis treatment facility. Pediatr Infect Dis J (2003) 1.44

Caesarean section and hospitalization for respiratory syncytial virus infection: a population-based study. Pediatr Infect Dis J (2015) 1.44

Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med (2002) 1.43

Pneumococcal capsular switching: a historical perspective. J Infect Dis (2012) 1.43

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine (2006) 1.43

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol (2009) 1.42

Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa. Int J Antimicrob Agents (2008) 1.40

Effect of rituximab on human in vivo antibody immune responses. J Allergy Clin Immunol (2011) 1.39

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis (2010) 1.39

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics (2006) 1.38